Search

everythinglearnresearchcommunity

for

Search:↓

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

Low-dose naltrexone and platelet-rich plasma can regrow hair in lichen planopilaris.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

TCF/Lef1 is essential for skin barrier function by regulating lipid metabolism.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

These hair loss conditions might be part of a spectrum, not separate issues.

FERONIA and LRX proteins help control cell growth in plants by regulating vacuole expansion.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

A feedback loop between LRH and RSL4 controls root hair growth in Arabidopsis.

Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.

Lupus and frontal fibrosing alopecia may share a common cause.

A 61-year-old Filipino man had a skin condition that looked like another disease, making diagnosis difficult.

The laser system helps study brain cell functions by precisely removing specific cells and observing changes.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

Sunscreen spray on the scalp may be linked to a type of scarring hair loss.

High LH levels cause hair loss by damaging and aging hair follicles.

Low-Level Laser Therapy might be a good alternative for hair loss when other treatments fail, but its effectiveness varies and more research is needed.

The 595-nm pulsed dye laser effectively reduces symptoms of EFFC with minimal side effects.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Lichen planopilaris can be accurately diagnosed and effectively treated.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

Wearing fire helmets may worsen lichen planopilaris in firefighters.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.